Industry
From U.S. (Toll Free) : +16467917070    |   UK : +442030260021     |    sales@businessmarketinsights.com

Czech Republic Enteral Nutrition Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others)

Report Code :  BMIRE00031052
No. of Pages :  82
Published Month :  Dec 2024
Category :  Pharmaceuticals
$299 per month

Best Plan
  • All Reports in One Industry
  • All Reports Read Access
  • Subscription Duration : 12 Months
  • Monthly New Reports Added
  • $1200 Yearly Saving

The Czech Republic enteral nutrition market size is projected to reach US$ 86.38 million by 2031 from US$ 56.42 million in 2023; the market is estimated to register a CAGR of 5.5% during 2023–2031.

Enteral nutrition, or "tube feeding," provides nutrition directly into the gastrointestinal (GI) tract using a feeding tube placed in the stomach or small intestine. Enteral nutrition consists of a liquid food mixture containing all essential nutrients, such as proteins, carbohydrates, fats, vitamins, and minerals. Formulas can be ready-to-feed liquids, powdered or concentrated mixtures, or blended foods. For infants, human breast milk or infant formula can also be considered EN when given through a feeding tube.

General or standard nutrition formulas may not be precise in providing patients with the quantities of nutrients required for the body to function correctly. Therefore, doctors prescribe nutrition products specific to diseases. Renal formulas are more calorically dense and contain lower concentrations of phosphorous, potassium, and magnesium than standard formulas. Similarly, pulmonary formulas feature less carbohydrate content than standard formulas. Pharmaceutical companies provide enteral nutrition with tailored constituents (patient-specific) to meet individual patient needs. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing primary elective surgery patients to reduce postoperative complications and length of hospital stays. The increasing prevalence of diseases like diabetes, kidney failure, and cancer leads to higher demand for disease-specific formulas in the Czech Republic.

The growth of home enteral nutrition is a noteworthy factor contributing to the expansion of the Czech Republic enteral nutrition market size. Home enteral nutrition allows patients to continue their nutritional therapy from the comfort of their homes, reducing hospital stays and minimizing healthcare costs. The Czech healthcare system places more emphasis on home care, which reduces the burden on hospital infrastructure, creating a demand for home enteral nutrition. Technological advancements that make at-home feeding more accessible and effective helps favoring the home enteral nutrition. For example, portable feeding pumps and smaller, easier-to-use feeding tubes enable patients to receive nutrition at home without the need for constant medical supervision. The convenience and comfort of receiving treatment at home are expected to make HEN a desirable option for many patients and their families.

Product Type-Based Insights

The Czech Republic enteral nutrition market, based on type, is segmented into nasogastric, nasoenteral, sipping, and others. The nasogastric segment held the largest share in the Czech Republic enteral nutrition market in 2023, and it is expected to register the highest CAGR during 2023–2031. Nasogastric feeding involves the insertion of a small tube into the stomach through the nose, offering a simple, cost-effective solution for providing nutrition to patients facing swallowing difficulties, neurological disorders, or severe conditions that impair oral intake. Nasogastric feeding helps patients get enough nutrition to recover from illness. Nasogastric feeding is commonly prescribed for patients who require short-term feeding support.

The demand for nasogastric feeding in the Czech Republic is driven by the increasing incidence of neurological disorders such as stroke, Parkinson's disease, and other conditions that affect swallowing. Additionally, the aging population in the country is contributing to the rise in the number of patients who require nutritional support, particularly after surgeries or in the management of chronic diseases. Healthcare infrastructure improvements and the availability of advanced, safer NG feeding tube systems are also encouraging the adoption of nasogastric enteral feeding.

The Organisation for Economic Co-operation and Development, International Society of Aesthetic Plastic Surgery, and World Health Organization are among the primary and secondary sources referred to while preparing the Czech Republic enteral nutrition market report.

  1. Nestle SA
  2.  Danone SA
  3. Abbott Laboratories
  4. Royal FrieslandCampina NV
  5. Fresenius SE & Co KGaA
  6. B Braun SE
  7. Reckitt Benckiser Group Plc
  8. Kate Farms Inc
  9. Dr Schar AG
  10. Fonterra Co-Operative Group Ltd
  11. Perrigo Co Plc
  12. Arla Foods amba
  13. Charing Cross Scientific AS
  14.  Bexen Medical
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Czech Republic enteral nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Czech Republic enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.